Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L

Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeb...

Full description

Bibliographic Details
Published in:Journal of Fish Diseases
Main Authors: Findlay, VL, Zilberg, D, Munday, BL
Format: Article in Journal/Newspaper
Language:English
Published: Blackwell Science Ltd 2000
Subjects:
Agricultural and Veterinary Sciences
Fisheries Sciences
Fish Pests and Diseases
Atlantic salmon
Salmo salar
Online Access:https://doi.org/10.1046/j.1365-2761.2000.00238.x
http://ecite.utas.edu.au/19014
Description
Summary:Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp. that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.

Similar Items